Insights

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Technology innovations are now able to start realising health concepts that have been talked about for years. As Stephanie Mou explains, insurmountable market advantage awaits the organisation that can establish a compelling delivery platform over the next five years… 

What does the future of next generation implantable drug delivery devices look like? Harry Moorman believes a CC concept breakthrough in smart, miniaturised active implant innovation offers significant opportunity for a market that is ripe for development and commercial growth…

CC’s findings in its report on the current and future state of smart cities in Japan have wider implications. As Jiahui Hermes explains, organisations intent on innovation in this space can benefit from exploring themes that are common to the challenges of smart infrastructure across a range of applications anywhere in the world…

The ophthalmology world is welcoming a new wave of sophisticated implant technology designed to transform diagnosis and treatment.

Among the participants at Cambridge Consultants unique ophthalmology technology innovation workshop were three renowned leaders in their respective fields, Professor Robert MacLaren, Elizabeth Yeu MD and Grayson Armstrong MD. In these exclusive interviews, they share their expert insights and their aspirations for the future of ophthalmology…

A rapidly growing global population is feeding a spiralling demand for precious energy and food resources. It also means that at the expected rate of growth, the world’s healthcare model is unsustainable. But I have a vision of a better future for healthcare, and a faith in the technology that will get us there…

The number of effective cell and gene therapies is growing rapidly, especially for treating ocular diseases. However, much less attention has been focused on the critical issue of delivery to the eye. 

These are crucial times for the future of ophthalmology. Technology wise, we are better placed than ever to confront the challenges. But continued innovation will not solve everything...

We have arrived at the most significant crossroads in ophthalmology that any of us can ever remember. It’s time for a bold vision of 2040 that all of us can share...

We're pleased to share that we’ve won a prestigious Red Dot Design Award for a holistic wearable medical device concept that puts the needs of Parkinson’s patients at the very core of its design.

Lizzie Thomas presents her case for designing improved, sustainable drug delivery devices. Currently, the approach is dominated at the outset by patient-centricity. This focus means that wider, more long-term implications simply aren’t considered early enough.